VAISHALI PHARMA
Back to Income Statement
|
VAISHALI PHARMA Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹99 Cr | ₹86 Cr | ₹70 Cr | ₹76 Cr | ₹54 Cr |
What is the latest Revenue of VAISHALI PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹99 Cr |
| Mar2024 | ₹86 Cr |
| Mar2023 | ₹70 Cr |
| Mar2022 | ₹76 Cr |
| Mar2021 | ₹54 Cr |
How is Revenue of VAISHALI PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹99 Cr | 14.77 | |
| Mar2024 | ₹86 Cr | 23.85 | |
| Mar2023 | ₹70 Cr | -8.12 | |
| Mar2022 | ₹76 Cr | 41.00 | |
| Mar2021 | ₹54 Cr | - | |
Compare Revenue of peers of VAISHALI PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VAISHALI PHARMA | ₹92.3 Cr | -5.1% | 6% | -44.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
VAISHALI PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VAISHALI PHARMA | -5.1% |
6% |
-44.1% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses